The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies
Open accessAbstract
Resistance to therapy is the major hurdle in the current cancer management. Cancer cells often rewire their cellular process to alternate mechanisms to resist the deleterious effect mounted by different therapeutic approaches. The major signaling pathways involved in the developmental process, such as Notch, Hedgehog, and Wnt, play a vital role in development, tumorigenesis, and also in the resistance to the various anticancer therapies. Understanding how cancer utilizes these developmental pathways in acquiring the resistance to the multi-therapeutic approach cancer can give rise to a new insight of the anti-therapy resistance mechanisms, which can be explored for the development of a novel therapeutic approach. We present a brief overview of Notch, Hedgehog, and Wnt signaling pathways in cancer and its role in providing resistance to various cancer treatment modalities such as chemotherapy, radiotherapy, molecular targeted therapy, and immunotherapy. Understanding the importance of these molecular networks will provide a rational basis for novel and safer combined anticancer therapeutic approaches for the improvement of cancer treatment by overcoming drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–211 of 211
Role of Notch Receptors in Hematologic Malignancies
Gragnani, L., Lorini, S., Marri, S., & Zignego, A. L. (2020) · Cells · doi:10.3390/cells10010016 · Cited by 21
Teichman, J., Dodbiba, L., Thai, H., Fleet, A., Morey, T., Liu, L., McGregor, M., Cheng, D., Chen, Z., Darling, G. E., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194809 · Cited by 20
Regulation of periostin expression by Notch signaling in hepatocytes and liver cancer cell lines
Kongkavitoon, P., Butta, P., Sanpavat, A., Bhattarakosol, P., Tangtanatakul, P., Wongprom, B., Tangkijvanich, P., Hirankarn, N., & Palaga, T. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.144 · Cited by 20
Oyama, Y., Onishi, H., Koga, S., Murahashi, M., Ichimiya, S., Nakayama, K., Fujimura, A., Kawamoto, M., Imaizumi, A., Umebayashi, M., et al. (2019) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000305 · Cited by 19
CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia
Duque‐Afonso, J., Lin, C.-H., Han, K., Morgens, D. W., Jeng, E. E., Weng, Z., Jeong, J., Wong, S. H. K., Zhu, L., Wei, M. C., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1703 · Cited by 16
Tomé, M., Tchorz, J. S., Gassmann, M., & Bettler, B. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101390 · Cited by 16
Suknuntha, K., Thita, T., Togarrati, P. P., Ratanachamnong, P., Wongtrakoongate, P., Srihirun, S., Slukvin, I. I., & Hongeng, S. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2116-x · Cited by 12
Hedgehog Pathway Activation Might Mediate Pemetrexed Resistance in NSCLC Cells
Liu, Y., Huber, R. M., Kiefl, R., Tufman, A., & Kauffmann-Guerrero, D. E. (2020) · Anticancer Research · doi:10.21873/anticanres.14087 · Cited by 11
PRKD2 Promotes Progression and Chemoresistance of AML via Regulating Notch1 Pathway
Liu, Q., Li, W., Zhou, Y. Y., Jian, J., Han, S., Liu, C., Li, W., Zhu, X., Ma, D., Ji, M., et al. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s233234 · Cited by 10
Maffei, R., Fiorcari, S., Martinelli, S., Benatti, S., Bulgarelli, J., Rizzotto, L., Debbia, G., Santachiara, R., Rigolin, G. M., Forconi, F., et al. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1339872 · Cited by 8
A Cell-Cycle “Safe Space” for Surviving Chemotherapy
Arora, M., & Spencer, S. L. (2017) · Cell Systems · doi:10.1016/j.cels.2017.09.010 · Cited by 8
Cited by
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances
Xue, C., Chu, Q., Shi, Q., Zeng, Y., Lu, J., & Li, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02142-w · Cited by 281
Self-citationCitarella, A., Catanzaro, G., Besharat, Z. M., Trocchianesi, S., Barbagallo, F., Gosti, G., Leonetti, M., Di Fiore, A., Coppola, L., Autilio, T. M., et al. (2023) · Cancers · doi:10.3390/cancers15051471 · Cited by 27
Zhang, W., Zhang, K., Ma, Y., Song, Y., Qi, T., Xiong, G., Zhang, Y., Kan, C., Zhang, J., Han, F., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115344 · Cited by 22
Metadata
- Authors
- Kumar, V., Vashishta, M., Kong, L., Wu, X., Lu, J. J., Guha, C., & Dwarakanath, B. S.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2021-04-22
- Volume
- 9
- Pages
- 650772-650772
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3156935377
- Cited by
- 255
- References
- 211
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.